Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
Aortic Stenosis
Interventions
DEVICE

Transfemoral transcatheter aortic valve implementation

ranscatheter aortic valve implantation, a percutaneous treatment for severe aortic valve stenosis, is increasingly performed worldwide. The pacemaker should be able to perform overdrive pacing which is essential to reduce cardiac output and transvalvular blood flow which are critical during balloon aortic valvuloplasty and valve deployment of the balloon- expandable valve. Minor adjustment may be needed for ideal positioning, but importantly this has to be done before valve implantation

Trial Locations (4)

47121

RECRUITING

AUSL Romagna Morgagni - Pierantoni Hospital, Forlì

48121

RECRUITING

Ospedale Santa Maria della Croci, Ravenna

Unknown

RECRUITING

Ospedale Generale Regionale F Miulli, Acquaviva delle Fonti

RECRUITING

Hospital del Mar, Barcelona

All Listed Sponsors
lead

AUSL Romagna Rimini

OTHER